Page last updated: 2024-08-07 15:42:22
Integrin alpha-V
An integrin alpha-V that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06756]
Synonyms
Vitronectin receptor;
Vitronectin receptor subunit alpha
Research
Bioassay Publications (58)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (18.97) | 18.2507 |
2000's | 20 (34.48) | 29.6817 |
2010's | 21 (36.21) | 24.3611 |
2020's | 6 (10.34) | 2.80 |
Compounds (22)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drugs with Other Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
mk-0429 | Homo sapiens (human) | SPAV3 | 0.0001 | 1 | 1 |
Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations.Journal of medicinal chemistry, , 06-11, Volume: 63, Issue:11, 2020
Molecular model of the alpha(IIb)beta(3) integrin.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp.Journal of medicinal chemistry, , Aug-05, Volume: 37, Issue:16, 1994
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.Journal of medicinal chemistry, , Nov-27, Volume: 35, Issue:24, 1992
Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides.Journal of medicinal chemistry, , Jul-10, Volume: 57, Issue:13, 2014
Molecular model of the alpha(IIb)beta(3) integrin.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.Bioorganic & medicinal chemistry letters, , Jan-07, Volume: 12, Issue:1, 2002
Exploring ACS medicinal chemistry letters, , Oct-13, Volume: 7, Issue:10, 2016
alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers.Journal of medicinal chemistry, , Nov-26, Volume: 52, Issue:22, 2009
Solid-phase synthesis of a nonpeptide RGD mimetic library: new selective alphavbeta3 integrin antagonists.Journal of medicinal chemistry, , Jun-07, Volume: 44, Issue:12, 2001
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.Journal of medicinal chemistry, , Aug-12, Volume: 42, Issue:16, 1999
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.Journal of medicinal chemistry, , Jul-18, Volume: 40, Issue:15, 1997
Sortase A-mediated cyclization of novel polycyclic RGD peptides for αBioorganic & medicinal chemistry letters, , 10-01, Volume: 73, 2022
Tuning the Biological Activity of RGD Peptides with Halotryptophans†.Journal of medicinal chemistry, , 01-14, Volume: 64, Issue:1, 2021
[no title available]Journal of medicinal chemistry, , 05-27, Volume: 64, Issue:10, 2021
Novel cilengitide-based cyclic RGD peptides as αvβBioorganic & medicinal chemistry letters, , 04-15, Volume: 30, Issue:8, 2020
Design and synthesis of novel dual-cyclic RGD peptides for αBioorganic & medicinal chemistry letters, , 04-01, Volume: 29, Issue:7, 2019
Cyclization of RGD Peptides by Suzuki-Miyaura Cross-Coupling.Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αJournal of medicinal chemistry, , 09-13, Volume: 61, Issue:17, 2018
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme.Journal of medicinal chemistry, , 06-14, Volume: 61, Issue:11, 2018
New potent and selective αvβBioorganic & medicinal chemistry letters, , 05-01, Volume: 27, Issue:9, 2017
Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.Bioorganic & medicinal chemistry, , Feb-15, Volume: 24, Issue:4, 2016
Insight to the binding mode of triazole RGD-peptidomimetics to integrin-rich cancer cells by NMR and molecular modeling.Bioorganic & medicinal chemistry, , Mar-01, Volume: 24, Issue:5, 2016
Pharmacophoric modifications lead to superpotent αvβ3 integrin ligands with suppressed α5β1 activity.Journal of medicinal chemistry, , Apr-24, Volume: 57, Issue:8, 2014
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.Journal of medicinal chemistry, , Aug-14, Volume: 57, Issue:15, 2014
Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides.Journal of medicinal chemistry, , Jul-10, Volume: 57, Issue:13, 2014
Synthesis and in vitro evaluation of a novel radioligand for αvβ3 integrin receptor imaging: [18F]FPPA-c(RGDfK).Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 23, Issue:22, 2013
Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Emerging targets in osteoporosis disease modification.Journal of medicinal chemistry, , Jun-10, Volume: 53, Issue:11, 2010
Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.Bioorganic & medicinal chemistry, , Feb-15, Volume: 17, Issue:4, 2009
Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.Bioorganic & medicinal chemistry, , Apr-15, Volume: 16, Issue:8, 2008
Discovery of subnanomolar arginine-glycine-aspartate-based alphaVbeta3/alphaVbeta5 integrin binders embedding 4-aminoproline residues.Journal of medicinal chemistry, , Mar-27, Volume: 51, Issue:6, 2008
Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.European journal of medicinal chemistry, , Volume: 42, Issue:3, 2007
Incorporation of the unusual C(alpha)-fluoroalkylamino acids into cyclopeptides: synthesis of arginine-glycine-aspartate (RGD) analogues and study of their conformational and biological behavior.Journal of medicinal chemistry, , Mar-09, Volume: 49, Issue:5, 2006
Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.Journal of medicinal chemistry, , Dec-01, Volume: 48, Issue:24, 2005
Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins.Journal of medicinal chemistry, , Feb-28, Volume: 45, Issue:5, 2002
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.Journal of medicinal chemistry, , Oct-09, Volume: 46, Issue:21, 2003
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic.Journal of medicinal chemistry, , Jan-13, Volume: 43, Issue:1, 2000
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimetics.Bioorganic & medicinal chemistry letters, , Jul-05, Volume: 9, Issue:13, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model.Bioorganic & medicinal chemistry letters, , Jul-05, Volume: 9, Issue:13, 1999
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 8, Issue:22, 1998
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.Bioorganic & medicinal chemistry letters, , Nov-17, Volume: 8, Issue:22, 1998
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.Journal of medicinal chemistry, , Jul-18, Volume: 40, Issue:15, 1997
Cyclization of RGD Peptides by Suzuki-Miyaura Cross-Coupling.Journal of medicinal chemistry, , 08-22, Volume: 62, Issue:16, 2019
Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application.ACS medicinal chemistry letters, , Jan-11, Volume: 9, Issue:1, 2018
Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αJournal of medicinal chemistry, , 01-12, Volume: 60, Issue:1, 2017
New β-Lactam Derivatives Modulate Cell Adhesion and Signaling Mediated by RGD-Binding and Leukocyte Integrins.Journal of medicinal chemistry, , 11-10, Volume: 59, Issue:21, 2016
Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.Journal of medicinal chemistry, , Dec-13, Volume: 55, Issue:23, 2012
Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging.Bioorganic & medicinal chemistry letters, , Apr-01, Volume: 21, Issue:7, 2011
Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.Journal of medicinal chemistry, , Jan-14, Volume: 53, Issue:1, 2010
Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.Bioorganic & medicinal chemistry, , Apr-15, Volume: 16, Issue:8, 2008
Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 16, Issue:22, 2006
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.Journal of medicinal chemistry, , Jun-01, Volume: 49, Issue:11, 2006
Incorporation of the unusual C(alpha)-fluoroalkylamino acids into cyclopeptides: synthesis of arginine-glycine-aspartate (RGD) analogues and study of their conformational and biological behavior.Journal of medicinal chemistry, , Mar-09, Volume: 49, Issue:5, 2006
Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.Journal of medicinal chemistry, , Dec-01, Volume: 48, Issue:24, 2005
Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the alpha V beta 3 receptor.Journal of medicinal chemistry, , Oct-25, Volume: 39, Issue:22, 1996
Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations.Journal of medicinal chemistry, , 06-11, Volume: 63, Issue:11, 2020
Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: part 2.Bioorganic & medicinal chemistry letters, , Jun-15, Volume: 22, Issue:12, 2012
Emerging targets in osteoporosis disease modification.Journal of medicinal chemistry, , Jun-10, Volume: 53, Issue:11, 2010
Nonpeptide alpha V beta 3 antagonists. Part 10: In vitro and in vivo evaluation of a potent 7-methyl substituted tetrahydro-[1,8]naphthyridine derivative.Bioorganic & medicinal chemistry letters, , Sep-06, Volume: 14, Issue:17, 2004
Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis.Journal of medicinal chemistry, , Oct-23, Volume: 46, Issue:22, 2003
Molecular model of the alpha(IIb)beta(3) integrin.Journal of medicinal chemistry, , Dec-04, Volume: 46, Issue:25, 2003
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin.Journal of medicinal chemistry, , Dec-19, Volume: 45, Issue:26, 2002
Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic.Journal of medicinal chemistry, , Jan-13, Volume: 43, Issue:1, 2000
Enables
This protein enables 11 target(s):
Target | Category | Definition |
virus receptor activity | molecular function | Combining with a virus component and mediating entry of the virus into the cell. [GOC:bf, GOC:dph, PMID:7621403, UniProtKB-KW:KW-1183] |
fibronectin binding | molecular function | Binding to a fibronectin, a group of related adhesive glycoproteins of high molecular weight found on the surface of animal cells, connective tissue matrices, and in extracellular fluids. [GOC:hjd] |
protease binding | molecular function | Binding to a protease or a peptidase. [GOC:hjd] |
integrin binding | molecular function | Binding to an integrin. [GOC:ceb] |
voltage-gated calcium channel activity | molecular function | Enables the transmembrane transfer of a calcium ion by a voltage-gated channel. A voltage-gated channel is a channel whose open state is dependent on the voltage across the membrane in which it is embedded. [GOC:mtg_transport, GOC:tb, ISBN:0815340729] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
coreceptor activity | molecular function | Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity. [GOC:go_curators] |
metal ion binding | molecular function | Binding to a metal ion. [GOC:ai] |
transforming growth factor beta binding | molecular function | Binding to TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types. [ISBN:0198506732] |
extracellular matrix binding | molecular function | Binding to a component of the extracellular matrix. [GOC:ai] |
extracellular matrix protein binding | molecular function | Binding to a protein that is part of an extracellular matrix. [PMID:22355679] |
Located In
This protein is located in 12 target(s):
Target | Category | Definition |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
focal adhesion | cellular component | A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ). [GOC:aruk, GOC:bc, ISBN:0124325653, ISBN:0815316208, PMID:10419689, PMID:12191915, PMID:15246682, PMID:1643657, PMID:16805308, PMID:19197329, PMID:23033047, PMID:26923917, PMID:28796323, PMID:8314002] |
cell surface | cellular component | The external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
lamellipodium membrane | cellular component | The portion of the plasma membrane surrounding a lamellipodium. [GOC:mah] |
filopodium membrane | cellular component | The portion of the plasma membrane surrounding a filopodium. [GOC:mah] |
microvillus membrane | cellular component | The portion of the plasma membrane surrounding a microvillus. [GOC:mah] |
ruffle membrane | cellular component | The portion of the plasma membrane surrounding a ruffle. [GOC:mah] |
specific granule membrane | cellular component | The lipid bilayer surrounding a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase. [GOC:bf, PMID:7334549] |
phagocytic vesicle | cellular component | A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis. [GOC:go_curators, ISBN:0198506732] |
extracellular exosome | cellular component | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
external side of plasma membrane | cellular component | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. [GOC:dos, GOC:tb] |
Part Of
This protein is part of 9 target(s):
Target | Category | Definition |
integrin alphav-beta1 complex | cellular component | An integrin complex that comprises one alphav subunit and one beta1 subunit. [PMID:12297042] |
integrin alphav-beta3 complex | cellular component | An integrin complex that comprises one alphav subunit and one beta3 subunit. [PMID:12297042] |
integrin alphav-beta5 complex | cellular component | An integrin complex that comprises one alphav subunit and one beta5 subunit. [PMID:12297042] |
integrin alphav-beta6 complex | cellular component | An integrin complex that comprises one alphav subunit and one beta6 subunit. [PMID:12297042] |
integrin alphav-beta8 complex | cellular component | An integrin complex that comprises one alphav subunit and one beta8 subunit. [PMID:12297042] |
integrin complex | cellular component | A protein complex that is composed of one alpha subunit and one beta subunit, both of which are members of the integrin superfamily of cell adhesion receptors; the complex spans the plasma membrane and binds to extracellular matrix ligands, cell-surface ligands, and soluble ligands. [PMID:17543136] |
alphav-beta3 integrin-PKCalpha complex | cellular component | A protein complex that consists of an alphav-beta3 integrin complex bound to protein kinase C alpha. [GOC:BHF, GOC:ebc, PMID:16014375] |
alphav-beta3 integrin-IGF-1-IGF1R complex | cellular component | A protein complex that consists of an alphav-beta3 integrin complex bound to insulin-like growth factor-1 (IGF-1) and type I insulin-like growth factor receptor (IGF1R). IGF1R is a heterotetramer that consists of two alpha-subunits and two beta-subunits. [GOC:BHF, GOC:ebc, PMID:19578119] |
alphav-beta3 integrin-HMGB1 complex | cellular component | A protein complex that consists of an alphav-beta3 integrin complex bound to high mobility group box 1 protein. [GOC:BHF, GOC:ebc, PMID:20826760] |
Involved In
This protein is involved in 36 target(s):
Target | Category | Definition |
angiogenesis | biological process | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. [ISBN:0878932453] |
vasculogenesis | biological process | The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. [PMID:8999798] |
cell adhesion | biological process | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. [GOC:hb, GOC:pf] |
cell-matrix adhesion | biological process | The binding of a cell to the extracellular matrix via adhesion molecules. [GOC:hb] |
positive regulation of cytosolic calcium ion concentration | biological process | Any process that increases the concentration of calcium ions in the cytosol. [GOC:ai] |
integrin-mediated signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to an integrin on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:mah, GOC:signaling] |
positive regulation of cell population proliferation | biological process | Any process that activates or increases the rate or extent of cell proliferation. [GOC:go_curators] |
negative regulation of macrophage derived foam cell differentiation | biological process | Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions. [GOC:add, GOC:BHF, GOC:dph, GOC:tb] |
negative regulation of lipid storage | biological process | Any process that decreases the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development. [GOC:BHF, GOC:dph, GOC:tb] |
cell migration | biological process | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. [GOC:cjm, GOC:dph, GOC:ems, GOC:pf, Wikipedia:Cell_migration] |
positive regulation of cell migration | biological process | Any process that activates or increases the frequency, rate or extent of cell migration. [GOC:go_curators] |
cell-substrate adhesion | biological process | The attachment of a cell to the underlying substrate via adhesion molecules. [GOC:mah, GOC:pf] |
negative regulation of lipid transport | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:mah] |
cell adhesion mediated by integrin | biological process | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits. [GOC:add, PMID:12213832, PMID:14754902] |
positive regulation of osteoblast proliferation | biological process | Any process that activates or increases the rate or extent of osteoblast proliferation. [GOC:mah] |
heterotypic cell-cell adhesion | biological process | The attachment of a cell to a cell of a different type via adhesion molecules. [GOC:add] |
substrate adhesion-dependent cell spreading | biological process | The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate. [GOC:mah, GOC:pf, PMID:17050732] |
wound healing, spreading of epidermal cells | biological process | The migration of an epidermal cell along or through a wound gap that contributes to the reestablishment of a continuous epidermis. [GOC:bf, PMID:15269788] |
endodermal cell differentiation | biological process | The process in which a relatively unspecialized cell acquires the specialized features of an endoderm cell, a cell of the inner of the three germ layers of the embryo. [CL:0000223, GOC:yaf, PMID:17624332] |
apolipoprotein A-I-mediated signaling pathway | biological process | The series of molecular signals initiated by apolipoprotein A-I binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:bf, GOC:signaling, PMID:16443932] |
apoptotic cell clearance | biological process | The recognition and removal of an apoptotic cell by a neighboring cell or by a phagocyte. [GOC:rk, PMID:14685684] |
positive regulation of cell adhesion | biological process | Any process that activates or increases the frequency, rate or extent of cell adhesion. [GOC:go_curators] |
symbiont entry into host cell | biological process | The process by which a symbiont breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the symbiont or its genome is released into the host cell. [GOC:jl] |
negative regulation of lipoprotein metabolic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids. [GOC:ai] |
regulation of phagocytosis | biological process | Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material. [GOC:ai] |
negative chemotaxis | biological process | The directed movement of a motile cell or organism towards a lower concentration of a chemical. [GOC:ai, GOC:bf, GOC:isa_complete] |
positive regulation of small GTPase mediated signal transduction | biological process | Any process that activates or increases the frequency, rate or extent of small GTPase mediated signal transduction. [GOC:ai] |
ERK1 and ERK2 cascade | biological process | A MAPK cascade containing at least the ERK1 or ERK2 MAP kinases. It starts with the activation of a MAP3K, and the consecutive activation of a MPK2K and of ERK1 or ERK2. The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier. The ERK1/ERK2 cascade is activated by mitogens, growth factors, G protein-coupled receptors, and results in cellular responses such as cell proliferation, cell differentiation and development. [PMID:20811974, PMID:23125017, PMID:28903453] |
calcium ion transmembrane transport | biological process | A process in which a calcium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore. [GOC:mah] |
transforming growth factor beta production | biological process | The appearance of any member of the transforming growth factor-beta family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Transforming growth factor-beta family members include TGF-B1, TGF-B2, and TGF-B3. [GOC:add, GOC:rv, PMID:16891311, PMID:2022183] |
entry into host cell by a symbiont-containing vacuole | biological process | The invasion by a symbiont of a cell of a host organism, forming a vacuole in which the symbiont resides. The vacuole membrane is formed from lipids and proteins derived from both host and symbiont. Begins when the symbiont attaches on to the host cell membrane which invaginates and deepens as the symbiont enters, and ends when the host cell membrane closes behind the newly-formed vacuole. [GOC:jl, PMID:18665841, PMID:8690024, PMID:9580555] |
extrinsic apoptotic signaling pathway in absence of ligand | biological process | The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. [GOC:mtg_apoptosis, PMID:15044679, PMID:20816705] |
positive regulation of intracellular signal transduction | biological process | Any process that activates or increases the frequency, rate or extent of intracellular signal transduction. [GOC:BHF, GOC:dph, GOC:signaling, GOC:tb, GOC:TermGenie] |
negative regulation of entry of bacterium into host cell | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of entry of bacterium into host cell. [GOC:obol] |
negative regulation of extrinsic apoptotic signaling pathway | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. [GOC:mtg_apoptosis] |
cell-cell adhesion | biological process | The attachment of one cell to another cell via adhesion molecules. [GOC:dos] |